The Cochrane Oral Health Group's Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL), Medline and Embase databases were searched with no language or date restrictions. Two ...

Maxillary sinus augmentation remains a cornerstone intervention for addressing insufficient bone height in the posterior maxilla prior to dental implant placement. Techniques such as the lateral ...

This procedure is often deemed necessary when a patient has insufficient bone height in the upper jaw that would otherwise support dental implants. As such, the surgery lifts the sinus membrane, ...

Question: I need implants, but my dentist said I need sinus-lift surgery first. Is this always needed? Answer: I have a similar dilemma. Do my tires always need to be rotated at every service visit?

New technique offers faster recovery, less discomfort, and better outcomes for patients previously told they were not candidates for dental implants. Unlike traditional sinus lift procedures, indirect ...

Recent med tech IPO candidate Intersect ENT ($XENT) has reported the results of three studies for its chronic sinusitis implants at the American Rhinologic Society ...

Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following ...

MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced ...

A 57-year-old woman in Italy who went to the doctor with inflamed sinuses and facial pain had an unusual diagnosis: a dental implant in the sinus. The woman had undergone oral surgery about two years ...

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the results of a ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT ®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced the U ...

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...